Diffusion of Prior Authorization Prohibition on Medications for Opioid Use Disorder: An Event History Analysis

• In Event: Diffusion and Collaboration Across Borders

Brief Overview

Examining determinants of removing prior authorization for medications for opioid use disorder in US state governments during 2010–2020, we find policy diffusion is driven more by states’ normative environment than healthcare cost competitiveness.

Authors

• Andrew Burk, University of Nebraska at Omaha

• William Swann, University of Nebraska at Omaha

• Serena Kim, North Carolina State University